Related Experiment Video

Updated: Nov 10, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.6K

An Update on the Role of Ubiquitination in Melanoma Development and Therapies

Frédéric Soysouvanh1, Serena Giuliano1, Nadia Habel1

  • 1Inserm U1065, C3M, Team 1, Biology, and Pathologies of Melanocytes, University of Nice Côte d'Azur, 06200 Nice, France.

Journal of Clinical Medicine
|April 3, 2021
PubMed

Insights

The ubiquitination system is crucial in melanoma development and therapy resistance. Targeting ubiquitination offers new therapeutic strategies for improving outcomes in cutaneous melanoma patients.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • The ubiquitination system regulates numerous biological processes.
  • Alterations in ubiquitination are implicated in cancer pathogenesis, particularly cutaneous melanoma.
  • Current advanced melanoma therapies face challenges due to intrinsic or acquired resistance.

Purpose of the Study:

  • To review the latest data on the role of ubiquitination in melanoma.
  • To discuss the potential impact of targeting ubiquitination in melanoma treatment.

Main Methods:

  • Literature review of recent research on ubiquitination in melanoma.
  • Analysis of the role of ubiquitination in melanoma development and therapy resistance.

Main Results:

  • Ubiquitination is a key regulator in various biological processes relevant to cancer.
  • Melanoma pathogenesis and resistance to targeted therapies and immunotherapies are linked to ubiquitination.
  • Each step of the ubiquitination pathway presents opportunities for pharmacological intervention.

Conclusions:

  • Ubiquitination is a promising area for novel therapeutic strategies in melanoma.
  • Targeting the ubiquitination system could overcome resistance mechanisms and improve patient prognosis in cutaneous melanoma.
Keywords:
melanomatreatmentubiquitination

More Related Videos

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

9.1K
In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones11:36

In Vitro Ubiquitination and Deubiquitination Assays of Nucleosomal Histones

Published on: July 25, 2019

11.1K

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.3K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
8.1K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K